To investigate the impact of hormonal therapy, particularly hormone resistance on BC T-ICs, SP cells were analysed in acquired tamoxifen-resistant MCF-7/TAM1 cells, aromatase-overexpressing Ac1 cells, and the acquired aromatase inhibitor anastrozole-resistant line, Ac1ANAR. Here, CYP19A1 is linked to breast cancer.